» Articles » PMID: 38002684

Cannabis and Endometriosis: The Roles of the Gut Microbiota and the Endocannabinoid System

Overview
Journal J Clin Med
Specialty General Medicine
Date 2023 Nov 25
PMID 38002684
Authors
Affiliations
Soon will be listed here.
Abstract

Endometriosis, a chronic condition affecting around 10-14% of women, is challenging to manage, due to its complex pathogenesis and limited treatment options. Research has suggested a potential role of the gut microbiota and the endocannabinoid system in the development and progression of endometriosis. This narrative review aims to explore the role of, and any potential interactions between, the endocannabinoid system (ECS) and the gut microbiota in endometriosis. This review found that both the ECS and microbiota influence endometriosis, with the former regulating inflammation and pain perception and the latter influencing immune responses and hormonal balance. There is evidence that a dysregulation of the endocannabinoid system and the gut microbiota influence endometriosis symptoms and progression via changes in CB1 receptor expression and increased circulating levels of endocannabinoids. Microbial imbalances in the gut, such as increases in , have been directly correlated to increased bloating, a common endometriosis symptom, while increases in have supported the bacterial contamination hypothesis as a potential pathway for endometriosis pathogenesis. These microbial imbalances have been correlated with increases in inflammatory markers such as TNF-α and IL-6, both often raised in those with endometriosis. Protective effects of the ECS on the gut were observed by increases in endocannabinoids, including 2-AG, resulting in decreased inflammation and improved gut permeability. Given these findings, both the ECS and the gut microbiota may be targets for therapeutic interventions for endometriosis; however, clinical studies are required to determine effectiveness.

Citing Articles

Optimization and Evaluation of -Based Magistral Formulations: A Path to Personalized Therapy.

Grimling B, Fast M, Okoniewska M, Owczarek A, Karolewicz B Pharmaceuticals (Basel). 2025; 18(1).

PMID: 39861136 PMC: 11768162. DOI: 10.3390/ph18010073.


Endometriosis: A Comprehensive Analysis of the Pathophysiology, Treatment, and Nutritional Aspects, and Its Repercussions on the Quality of Life of Patients.

Cano-Herrera G, Salmun Nehmad S, Ruiz de Chavez Gascon J, Mendez Vionet A, van Tienhoven X, Osorio Martinez M Biomedicines. 2024; 12(7).

PMID: 39062050 PMC: 11274817. DOI: 10.3390/biomedicines12071476.

References
1.
Leonardi M, Gibbons T, Armour M, Wang R, Glanville E, Hodgson R . When to Do Surgery and When Not to Do Surgery for Endometriosis: A Systematic Review and Meta-analysis. J Minim Invasive Gynecol. 2019; 27(2):390-407.e3. DOI: 10.1016/j.jmig.2019.10.014. View

2.
Castillo P, Younts T, Chavez A, Hashimotodani Y . Endocannabinoid signaling and synaptic function. Neuron. 2012; 76(1):70-81. PMC: 3517813. DOI: 10.1016/j.neuron.2012.09.020. View

3.
Maldonado R, Banos J, Cabanero D . The endocannabinoid system and neuropathic pain. Pain. 2016; 157 Suppl 1:S23-S32. DOI: 10.1097/j.pain.0000000000000428. View

4.
Cluny N, Keenan C, Reimer R, Le Foll B, Sharkey K . Prevention of Diet-Induced Obesity Effects on Body Weight and Gut Microbiota in Mice Treated Chronically with Δ9-Tetrahydrocannabinol. PLoS One. 2015; 10(12):e0144270. PMC: 4669115. DOI: 10.1371/journal.pone.0144270. View

5.
Khan K, Kitajima M, Hiraki K, Yamaguchi N, Katamine S, Matsuyama T . Escherichia coli contamination of menstrual blood and effect of bacterial endotoxin on endometriosis. Fertil Steril. 2010; 94(7):2860-3.e1-3. DOI: 10.1016/j.fertnstert.2010.04.053. View